Best Fertility Center
Best Fertility Center
At Best Life Fertility Centre, we understand that the journey to parenthood involves many important decisions. Genetic screening offers prospective parents the opportunity to make informed choices, reducing the risk of passing on genetic conditions and increasing the chances of a successful pregnancy.
Genetic screening involves analyzing embryos created through IVF to detect potential genetic abnormalities. This process helps identify embryos with the best chance of developing into healthy pregnancies.
Types of Genetic Screening
* Detects chromosomal abnormalities that can lead to implantation failure, miscarriage, or congenital disorders.
Identifies specific inherited genetic conditions, such as cystic fibrosis or thalassemia, especially when there’s a known family history.
Eggs are retrieved from the ovaries and fertilized with sperm in the laboratory.
Fertilized embryos are cultured for several days until they reach the blastocyst stage.
A few cells are carefully removed from each embryo without harming its development.
The biopsied cells are sent to a specialized laboratory to analyze the genetic material.
Based on the results, embryos without genetic abnormalities are selected for transfer.
Genetic screening may be recommended for:
We recognize that the decision to undergo genetic screening is deeply personal. Our team at Best Life Fertility Centre is dedicated to providing:
Helping you understand the benefits, limitations, and implications of genetic screening.
Offering guidance and support throughout your fertility journey.
Tailoring treatment plans to your unique needs and circumstances.
Preimplantation genetic testing (PGT) is a type of genetic testing performed during IVF to screen embryos for genetic disorders or chromosomal abnormalities before they are transferred to the uterus.
PGT involves taking a small biopsy of cells from an embryo and testing it for genetic abnormalities using techniques such as array comparative genomic hybridization or next-generation sequencing. By selecting chromosomally normal embryos, PGT can increase the chances of a successful pregnancy and reduce the risk of miscarriage or genetic disorders. PGT can also be used for sex selection or to match embryos for HLA compatibility.
preimplantation genetic diagnosis (PGT)?
Embryos that are chromosomally normal and free of genetic disorders or abnormalities are identified before they are transferred to the uterus during an IVF cycle. By selecting healthy embryos, PGD can increase the chances of a successful pregnancy and reduce the risk of miscarriage or genetic disorders. It can also be used for sex selection or embryo matching for compatibility. It can provide valuable information to help guide medical decision-making and improve outcomes.
Carrier screening is a type of genetic testing performed on individuals to determine whether they are carriers of certain genetic disorders that can be passed on to their children. Carrier screening can be performed before or during pregnancy and involves analyzing DNA samples to determine whether an individual carries mutations in specific genes associated with genetic disorders.
I am item content. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Carrier screening is performed to identify carriers of certain genetic disorders that can be passed on to their children. Many genetic disorders are caused by mutations in specific genes inherited from parents who carry the mutation but may not exhibit symptoms of the disorder themselves. Identifying carriers of genetic disorders can help prospective parents make informed decisions about their reproductive options, such as using assisted reproductive technologies (ARTs) like in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD), to prevent the transmission of genetic disorders to their children. Carrier screening can also aid in family planning by identifying the risks of having a child with a genetic disorder, allowing individuals and couples to make informed decisions about childbearing and seek appropriate medical care. Overall, carrier screening can help prevent the transmission of genetic disorders and promote healthy pregnancies and families.
Human leukocyte antigen or HLA
HLA (human leukocyte antigen) matching is the process of matching the HLA characteristics of a patient and a donor for organ or tissue transplantation. HLA molecules play an important role in immune system recognition, and matching HLA characteristics between donor and recipient helps reduce the risk of organ or tissue transplant rejection. HLA matching is also used in the selection of stem cell or bone marrow donors for transplantation.
HLA matching is performed to reduce the risk of rejection in organ, tissue, or stem cell transplants. HLA molecules are important for immune system recognition, and a close match between the HLA characteristics of the donor and recipient can help reduce the likelihood that the recipient’s immune system will recognize the transplanted cells as foreign and attack them. This can improve the success of the transplant and the long-term health of the recipient.
Family Balance
Preimplantation genetic testing (PGT) is the most effective method for gender selection. In PGT, the patient undergoes in vitro fertilization (IVF) to test multiple embryos.
A single cell or blastomere removed from each embryo is tested for X and Y chromosome material. Only embryos of the desired sex are then transferred, achieving up to 100% correct sex determination and selection.
If you’re considering genetic screening as part of your fertility plan, we’re here to help.
Best Life Fertility Centre
Helping you achieve your dream of parenthood with advanced fertility treatments, compassionate care, and personalized support — every step of the way.
©2025 Bestivf.ae All Rights Reserved.
Powered by Cielo Creatives
